CNE1000041J5
CNE1000041J5
EYEBRIGHT MEDICAL TECHNOLOGY (B
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 7.58B EUR | 7.05B EUR | 10.03B EUR |
Enterprise Value | 8.33B EUR | 7.66B EUR | 10.61B EUR |
Valuation Multiples | |||
Trailing P/E | 32.1x | 25.06x | 35.74x |
Forward P/E | 17.96x | -- | -- |
Price to Sales | 4.65x | 4.15x | 6.58x |
Price to Book | 2.62x | 2.44x | 3.5x |
EV/Revenue | 5.12x | 4.5x | 6.96x |
EV/EBITDA | 16.54x | 17.37x | 24.49x |
Price to FCF (P/FCF) | -- | 32.86x | 56.12x |
EV/FCF | -- | 35.67x | 59.35x |
FCF Yield | -0.19% | 3.04% | 1.78% |